Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Thoracic Malignancies
Do you recommend consolidation immunotherapy after SBRT or surgery and chemo for T1-T2N0 SCLC?
Related Questions
Would you offer adjuvant radiation therapy for a completely resected, node positive mucoepidermoid carcinoma of the lung?
What is your planning approach for SBRT when the tumor abuts the great vessels such as aortic arch or SVC?
How do you approach a patient with stage IIA non-small cell lung cancer who received SBRT?
Does receipt of chemoimmunotherapy for LS-SCLC impact your recommendation for PCI?
Would you offer lung SBRT in a patient with Pulmonary Langerhans Cell Histiocytosis (PLCH)?
Would you offer SBRT as an alternative to surgery for an atypical carcinoid lung tumor?
How do you construct your target volumes for superior sulcus tumors?
Is there any role for adjuvant radiotherapy for resected multistation N2 atypical carcinoid tumor of the lung?
Do you use an LAD constraint in the setting of BID thoracic radiation for SCLC?
What constraints do you use for the BID small cell lung cancer regimen?
